Clinical Trials
1,079 trialsPASSAT
AstraZeneca
OSIREAL
AstraZeneca
MK-3475-U01
Merck Sharp & Dohme LLC
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
National Institutes of Health Clinical Center (CC)
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
National Institutes of Health Clinical Center (CC)
NAUTIC
AstraZeneca
CHOICE
AstraZeneca
IMOTION
Nanfang Hospital, Southern Medical University
DESCENT-1
A2 Biotherapeutics Inc.
Repotrectinib Post-Marketing Surveillance in Korean Patients With ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) or Solid Tumors Harboring a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion
Bristol-Myers Squibb
FOREFRONT
AstraZeneca
Tumor-informed MRD for Non-small Cell Lung Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
MYLUNG
US Oncology Research
MYLUNG
US Oncology Research
ALCG-01
Gazi University
SECURE
AstraZeneca
Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
National Cancer Centre, Singapore
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
CEMI-LUNG
Regeneron Pharmaceuticals
SISTEMA
ASL Lecce
A Study in Non-Small Cell Lung Cancer
N-Power Medicine
MAP
AstraZeneca
3D Virtual Resection for Predicting Lung Function in VATS
National Taiwan University Hospital
Molecular Profiling Project
National Cancer Centre, Singapore
Emulation of the KEYNOTE-042 (NCT02220894) Trial Using Specialty Oncology Electronic Health Records Databases
Brigham and Women's Hospital
A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment
Pfizer
PLuS2
University of Florida
NYULCBC
NYU Langone Health
LEPIDOPTERA
Janssen Research & Development, LLC
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study
M.D. Anderson Cancer Center
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Hoffmann-La Roche
TRACERx
University College, London
LOOP
AstraZeneca
Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
University of Utah
Harvesting Cells for Experimental Cancer Treatments
National Institutes of Health Clinical Center (CC)
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
University of Missouri-Columbia
E20241186
Tianjin Medical University Cancer Institute and Hospital
OMAE
Groupe Francais De Pneumo-Cancerologie
BASECAMP-1
A2 Biotherapeutics Inc.
TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%
Antalya Training and Research Hospital
NUTRI-CPNM
Fundacin Biomedica Galicia Sur
CYBRID-01
Elephas
ELEPHAS-02
Elephas
Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC
Fudan University
LUNGEVITY
Groupe Francais De Pneumo-Cancerologie
Multimodal CT-Based Risk Stratification for Postoperative Local Recurrence in NSCLC: A Multicenter Study
Jinling Hospital, China
Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques
Second Affiliated Hospital, School of Medicine, Zhejiang University
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
Wake Forest University Health Sciences
SCORACLE
Central Hospital, Nancy, France